Newborn Brain Function Is Affected by Fetal Exposure to Maternal Serotonin Reuptake Inhibitors

Cerebral Cortex

Volumn 27, Issue 6, 2017, Pages 3208-3216

  Videman, Mari ^a,h   Tokariev, Anton ^b,d   Saikkonen, Heini ^c,e   Stjerna, Susanna ^b   Heiskala, Hannu ^a   Mantere, Outi ^e,f,g   Vanhatalo, Sampsa ^b  

^a Department of Children and Adolescents   (United Kingdom)

^b HUS Medical Imaging Center and Children's Hospital   (United Kingdom)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f MCGILL UNIVERSITY   (Canada)

^g DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^h UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

depression; EEG; neonatal; pregnancy; SSRI

Indexed keywords

CITALOPRAM; DULOXETINE; ESCITALOPRAM; MIRTAZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BRAIN ASYMMETRY; BRAIN FUNCTION; CLINICAL ARTICLE; CONNECTOME; CONTROLLED STUDY; DEPRESSION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MOVEMENT (PHYSIOLOGY); NEWBORN; NEWBORN ASSESSMENT; ORIENTATION; PERINATAL DRUG EXPOSURE; POSTNATAL DEPRESSION; PRIORITY JOURNAL; STARTLE REFLEX; TREMOR; WAKEFULNESS; WITHDRAWAL SYNDROME; ANXIETY; BRAIN; BRAIN MAPPING; CHEMICALLY INDUCED; CHILD; DRUG EFFECTS; DRUG THERAPY; ELECTROENCEPHALOGRAM; HEMISPHERIC DOMINANCE; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; PRESCHOOL CHILD; PSYCHOLOGICAL RATING SCALE; YOUNG ADULT;

ADULT; ANXIETY; BRAIN; BRAIN MAPPING; BRAIN WAVES; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 85026870648     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhw153     Document Type: Article

References (60)

1. Amodeo LR, Greenfield VY, Humphrey DE, Varela V, Pipkin JA, Eaton SE, Johnson JD, Plant CP, Harmony ZR, Wang L, et al. 2015. Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats. Psychopharmacology (Berl). 232(19):3515-3528.
2. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, et al. 2008. Use of antidepressant medications during pregnancy: A multisite study. Am J Obstet Gynecol. 198(2):194. e1-194. e5.
3. Andre M, Lamblin MD, d'Allest AM, Curzi-Dascalova L, Moussalli-Salefranque F, S Nguyen The T, Vecchierini-Blineau MF, Wallois F, Walls-Esquivel E, Plouin P. 2010. Electroencephalography in premature and full-term infants developmental features and glossary. Neurophysiol Clin. 40(2):59-124.
4. Babor T, Higgins-Biddle J, Saunders J, Monteiro M. 2001. AUDIT the alcohol use disorders identification test guidelines for use in primary care. 2nd ed. Geneva, Switzerland: WHO. General Department of Mental Health and Substance Dependence.
5. Beck AT, Epstein N, Brown G, Steer RA. 1988. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 56(6):893-897.
6. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. 1961. An inventory for measuring depression. Arch Gen Psychiatry. 4:561-571.
7. Biagioni E, Frisone MF, Laroche S, Kapetanakis BA, Ricci D, Adeyi-Obe M, Lewis H, Kennea N, Cioni G, Cowan F, et al. 2007. Maturation of cerebral electrical activity and development of cortical folding in young very preterm infants. Clin Neurophysiol. 118(1):53-59.
8. Borue X, Chen J, Condron BG. 2007. Developmental effects of SSRIs: lessons learned from animal studies. Int J Dev Neurosci. 25(6):341-347.
9. Bourke CH, Stowe ZN, Neigh GN, Olson DE, Owens MJ. 2013. Prenatal exposure to escitalopram and/or stress in rats produces limited effects on endocrine, behavioral, or gene expression measures in adult male rats. Neurotoxicol Teratol. 39:100-109.
10. Charlton RA, Jordan S, Pierini A, Garne E, Neville AJ, Hansen AV, Gini R, Thayer D, Tingay K, Puccini A, et al. 2015. Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: A population-based study in six European regions. BJOG. 122(7):1010-1020.
11. Clancy B, Finlay BL, Darlington RB, Anand KJ. 2007. Extrapolating brain development from experimental species to humans. Neurotoxicology. 28(5):931-937.
12. Colonnese MT, Kaminska A, Minlebaev M, Milh M, Bloem B, Lescure S, Moriette G, Chiron C, Ben-Ari Y, Khazipov R. 2010. A conserved switch in sensory processing prepares developing neocortex for vision. Neuron. 67(3):480-498.
13. Dawson AL, Razzaghi H, Arth A, Canfield MA, Parker SE, Reefhuis J, National Birth Defects Prevention Study. 2015. Maternal exposures in the national birth defects prevention study: Time trends of selected exposures. Birth Defects Res A Clin Mol Teratol. 103(8):703-712.
14. Diego MA, Jones NA, Field T. 2010. EEG in 1-week, 1-month and 3-month-old infants of depressed and non-depressed mothers. Biol Psychol. 83(1):7-14.
15. Dubowitz M, Dubowitz V, Mercuri E. 1999. The neurological assessment of the preterm and full-term newborn infant. 2nd ed. London: Mac Keith Press.
16. Durrmeyer X, Vutskits L, Anand KJ, Rimensberger PC. 2010. Use of analgesic and sedative drugs in the NICU: integrating clinical trials and laboratory data. Pediatr Res. 67(2):117-127.
17. Engel AK, Gerloff C, Hilgetag CC, Nolte G. 2013. Intrinsic coupling modes: multiscale interactions in ongoing brain activity. Neuron. 80(4):867-886.
18. Field T, Diego M. 2008. Maternal depression effects on infant frontal EEG asymmetry. Int J Neurosci. 118(8):1081-1108.
19. Finnegan L, Kaltenback K. 1992. Neonatal abstinence syndrome. In: Hoekelman RA, Friedman SB, Nelson N, Seidel HM, editors. Primary pediatric care. 2nd ed. St Louis: CV Mosby. p. 1367.
20. Forsberg L, Naver L, Gustafsson LL, Wide K. 2014. Neonatal adaptation in infants prenatally exposed to antidepressants-clinical monitoring using neonatal abstinence score. PLoS ONE. 9 (11):e111327.
21. Gentile S. 2005. The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf. 28(2):137-152.
22. Gentile S. 2015. Untreated depression during pregnancy: shortand long-term effects in offspring. A systematic review. Neuroscience [Epub ahead of print].
23. Goldstein BL, Klein DN. 2014. A review of selected candidate endophenotypes for depression. Clin Psychol Rev. 34(5): 417-427.
24. Hahn JS, Tharp BR. 1990. Winner of the Brazier award. The dysmature EEG pattern in infants with bronchopulmonary dysplasia and its prognostic implications. Electroencephalogr Clin Neurophysiol. 76(2):106-113.
25. Hanley GE, Brain U, Oberlander TF. 2015. Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior. Pediatr Res. 78(2):174-180.
26. Hanley GE, Mintzes B. 2014. Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance. BMC Pregnancy Childbirth. 14:242-253.
27. Hermansen TK, Melinder A. 2015. Prenatal SSRI exposure: effects on later child development. Child Neuropsychol. 21 (5):543-569.
28. Homberg JR, Schubert D, Gaspar P. 2010. New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol Sci. 31(2):60-65.
29. Hyafil A, Giraud AL, Fontolan L, Gutkin B. 2015. Neural crossfrequency coupling: connecting architectures, mechanisms, and functions. Trends Neurosci. 38(11):725-740.
30. Kieviet N, Dolman KM, Honig A. 2013. The use of psychotropic medication during pregnancy: how about the newborn Neuropsychiatr Dis Treat. 9:1257-1266.
31. Kiryanova V, McAllister BB, Dyck RH. 2013. Long-term outcomes of developmental exposure to fluoxetine: A review of the animal literature. Dev Neurosci. 35(6):437-439.
32. Koolen N, Dereymaeker A, Räsänen O, Jansen K, Vervisch J, Matic V, De Vos M, Van Huffel S, Naulaers G, Vanhatalo S. 2014. Interhemispheric synchrony in the neonatal EEG revisited: Activation synchrony index as a promising classifier. Front Hum Neurosci. 8:1030.
33. Liao CC, Lee LJ. 2011. Neonatal fluoxetine exposure affects the action potential properties and dendritic development in cortical subplate neurons of rats. Toxicol Lett. 207(3):314-321.
34. Lusby CM, Goodman SH, Bell MA, Newport DJ. 2014. Electroencephalogram patterns in infants of depressed mothers. Dev Psychobiol. 56(3):459-473.
35. Malm H, Sourander A, Gissler M, Gyllenberg D, Hinkka-Yli-Salomaki S, McKeague IW, Artama M, Brown AS. 2015. Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from population-based national register data. Am J Psychiatry. 172(12):1224-1232.
36. Man KK, Tong HH, Wong LY, Chan EW, Simonoff E, Wong IC. 2015. Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: A systematic review and meta-analysis of observational studies. Neurosci Biobehav Rev. 49:82-89.
37. Minlebaev M, Ben-Ari Y, Khazipov R. 2007. Network mechanisms of spindle-burst oscillations in the neonatal rat barrel cortex in vivo. J Neurophysiol. 97:692-700.
38. NoorlanderCW, Ververs FF, Nikkels PG, van Echteld CJ, Visser GH, Smidt MP. 2008. Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS ONE. 3(7): e2782.
39. Nordquist N, Oreland L. 2010. Serotonin, genetic variability, behaviour, and psychiatric disorders-a review. Ups J Med Sci. 115(1):2-10.
40. Nunes ML, Khan RL, Gomes Filho I, Booij L, da Costa JC. 2014. Maturational changes of neonatal electroencephalogram: A comparison between intra uterine and extra uterine development. Clin Neurophysiol. 125(6):1121-1128.
41. Oberlander T, Gingrich J, Ansorge M. 2009. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther. 86(6):672-677.
42. Persico AM, Mengual E, Moessner R, Hall FS, Revay RS, Sora I, Arellano J, DeFelipe J, Gimenez-Amaya JM, Conciatori M, et al. 2001. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci. 21(17):6862-6873.
43. Räsänen O, Metsäranta M, Vanhatalo S. 2013. Development of a novel robust measure for interhemispheric synchrony in the neonatal EEG: Activation synchrony index (ASI). Neuroimage. 69:256-266.
44. Ray S, Stowe ZN. 2014. The use of antidepressant medication in pregnancy. Best Pract Res Clin Obstet Gynaecol. 28(1):71-83.
45. Reefhuis J, Devine O, Friedman JM, Louik C, Honein MA, National Birth Defects Prevention Study. 2015. Specific SSRIs and birth defects: Bayesian analysis to interpret newdata in the context of previous reports. Br Med J. 351:h3190.
46. Salisbury AL, O'Grady KE, Battle CL, Wisner KL, Anderson GM, Stroud LR, Miller-Loncar CL, Young ME, Lester BM. 2016. The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month. Am J Psychiatry. 173(2):147-157.
47. Salisbury AL, Wisner KL, Pearlstein T, Battle CL, Stroud L, Lester BM. 2011. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depress Anxiety. 28(11):1008-1019.
48. Simpson KL, Weaver KJ, de Villers-Sidani E, Lu JY, Cai Z, Pang Y, Rodriguez-Porcel F, Paul IA, Merzenich M, Lin RC. 2011. Perinatal antidepressant exposure alters cortical network function in rodents. Proc Natl Acad Sci USA. 108(45):18465-18470.
49. Sotero RC, Bortel A, Naaman S, Mocanu VM, Kropf P, Villeneuve M, Shmuel A. 2015. Laminar distribution of phase-amplitude coupling of spontaneous current sources and sinks. Front Neurosci. 9:454.
50. Suri D, Teixeira CM, Cagliostro MK, Mahadevia D, Ansorge MS. 2015. Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors. Neuropsychopharmacology. 40(1):88-112.
51. Ter Horst P, Jansman F, van Lingen R, Smit J, de Jong-van den Berg LT, Brouwers J. 2008. Pharmacological aspects of neonatal antidepressant withdrawal. Obstet Gynecol Surv. 63 (4):267-279.
52. Thibodeau R, Jorgensen RS, Kim S. 2006. Depression, anxiety, and resting frontal EEG asymmetry: A meta-analytic review. J Abnorm Psychol. 115(4):715-729.
53. Tokariev A, Palmu K, Lano A, Metsäranta M, Vanhatalo S. 2012. Phase synchrony in the early preterm EEG: development of methods for estimating synchrony in both oscillations and events. Neuroimage. 60(2):1562-1573.
54. Tokariev A, Videman M, Palva JM, Vanhatalo S. 2015. Functional brain connectivity develops rapidly around term age and changes between vigilance states in the human newborn. Cereb Cortex [Epub ahead of print].
55. Vanhatalo S, Palva JM, Andersson S, Rivera C, Voipio J, Kaila K. 2005. Slowendogenous activity transients and developmental expression of K+-Cl cotransporter 2 in the immature human cortex. Eur J Neurosci. 22(11):2799-2804.
56. Videman M, Tokariev A, Stjerna S, Roivainen R, Gaily E, Vanhatalo S. 2016. Effects of prenatal antiepileptic drug exposure on newborn brain activity. Epilepsia. 57(2):252-262.
57. WarburtonW, Hertzman C, Oberlander T. 2010. A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health. Acta Psychiatr Scand. 121(6):471-479.
58. Wemakor A, Casson K, Garne E, Bakker M, Addor MC, Arriola L, GattM, Khoshnood B, Klungsoyr K, Nelen V, et al. 2015. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: A European register-based study. Eur J Epidemiol. 30(11):1187-1198.
59. Xu Y, Sari Y, Zhou FC. 2004. Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development. Brain Res Dev Brain Res. 150 (2):151-161.
60. Zhou X, Lu JY, Darling RD, Simpson KL, Zhu X, Wang F, Yu L, Sun X, Merzenich MM, Lin RC. 2015. Behavioral training reverses global cortical network dysfunction induced by perinatal antidepressant exposure. Proc Natl Acad Sci USA. 112 (7):2233-2238.